FDA News
Washington Drug Letter
For more than 40 years, WDL’s team of journalists has been the eyes and ears of pharmaceutical executives in Washington when it comes to the US Congress and agencies like FDA, NIH, CMS, DOJ, FTC, and the HHS Office of the Inspector General. WDL covers enforcement activities, rulemaking, guidance development, court cases and precedents, congressional actions and new laws affecting the industry. In every issue, you get links to important documents, such as FDA letters, guidances, rules, full texts of proposed legislation, GAO reports and more. NEW 2013 FEATURES: You will now get weekly information on new warning letters, what is buzzing at the FDA, the FDA calendar, the most recent FOIA requests and current court and legislative actions.
|
|
|
Your shopping cart is empty
-
Come for this valuable opportunity to hear FDA officials discuss regulatory plans and objectives — and ask questions you need answered; learn from device industry experts, consultants and other experts with actionable tips and strategies you can take straight back to the office; and network with other professionals who understand your challenges; share war stories and insights over a drink. Register Today.
Read More
-
The FDA's new enforcement plan makes one thing clear: Developing a successful CAPA program has never been more important. But creating an FDA-proof CAPA isn’t easy. If only you could pick the brain of someone who is coping successfully with CAPA — the best and the brightest, an industry leader who has devised programs, procedures and solutions that have put companies out in front with the FDA. Well, you can. Register today.
Read More
-
The FDA’s cadre of freshly trained inspectors — many of whom come directly from industry — and increased focus on specialized inspections are making it harder than ever to predict the outcome of your next FDA inspection. Unless, of course, you have Surviving an FDA Inspection at your fingertips. If you could spend less than $400 to get your drug manufacturing facility fully prepared to face a tough inspection by the FDA, would you even hesitate? ... Of course not!
Read More
|
Subscribe
Archives